Nephro Care India Ltd
Ticker: NEPHROCARE
Decent
66/100
☆ Add to Watchlist
Investing Reference
Price
136.30
Market Cap
224.71
Debt/Equity
0.0000
ROE %
10.655
PB
4.2010
Promoter %
61.469
Pledge %
0.000
1Y Rev Growth %
70.458
5Y Rev Growth %
144.095
NP Margin %
7.658
NP Margin 5Y Avg %
8.156
Trading Reference
1M Return %
-3.071
6M Return %
-4.685
1Y Return %
-44.840
% Away 52W High
92.810
% Away 52W Low
36.368
Daily Volume
44000
Investment Verdict
Hold
Score 66/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 21/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
Nephro Care India Ltd is a leading provider of dialysis services, showing steady growth in a critical healthcare segment.
✅ Positives
- Strong demand for dialysis services in India
- Established network of clinics across major cities
- Consistent revenue growth and profitability
⚠️ Negatives
- High operational costs impacting margins
- Regulatory challenges in healthcare sector
- Intense competition from other healthcare providers
Verdict
Moderate growth potential with some risks.
Recommendation: Consider buying on dips.
Upside Probability: 25% | Downside Probability: 15%
Last generated: 30/10/2025
More Options
B
Brahmaputra Infrastructure Ltd
Brahmaputra Infrastructure Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
J
Jeyyam Global Foods Ltd
Jeyyam Global Foods Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
G
Gennex Laboratories Ltd
Gennex Laboratories Ltd shows potential but faces significant risks and inconsistencies in growth and profitability.
View details
A
Addictive Learning Technology Ltd
The stock has potential but is hindered by inconsistent growth and profitability metrics. Caution is advised.
View details
E
Emerald Finance Ltd
Emerald Finance Ltd presents several risks with inconsistent growth and weak market sentiment, making it a risky investment at this time.
View details
S
SAL Steel Ltd
SAL Steel Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
E
Esconet Technologies Ltd
Esconet Technologies Ltd presents a mixed outlook with some growth potential, but significant risks and inconsistencies in performance metrics warrant caution.
View details
S
S V Global Mill Ltd
S V Global Mill Ltd shows several weaknesses in growth and profitability metrics, indicating a risky investment.
View details
R
Radix Industries (India) Ltd
Radix Industries shows some potential but faces challenges in growth consistency and profitability metrics.
View details
M
Murudeshwar Ceramics Ltd
The stock shows moderate potential but lacks strong growth drivers and market momentum.
View details
C
CP Capital Ltd
CP Capital Ltd faces significant challenges in growth and profitability, with risks outweighing potential rewards.
View details
D
Dharan Infra-EPC Ltd
Dharan Infra-EPC Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
View details
S
Sakthi Sugars Ltd
Sakthi Sugars Ltd presents a risky investment due to inconsistent growth and profitability metrics, alongside governance concerns.
View details
O
Oxygenta Pharmaceutical Ltd
Oxygenta Pharmaceutical Ltd shows potential but faces significant risks and challenges in the current market environment.
View details
B
B C C Fuba India Ltd
B C C Fuba India Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
View details
V
Vijay Solvex Ltd
Vijay Solvex Ltd shows potential but faces challenges in growth consistency and valuation metrics. Caution is advised.
View details
Business Overview
Nephro Care India Ltd is a leading provider of kidney care services in India, dedicated to improving the quality of life for patients with renal diseases. Catering to individuals seeking reliable and compassionate dialysis and nephrology services, the company plays a crucial role in the healthcare ecosystem. With a focus on patient-centric care and advanced treatment options, Nephro Care is committed to excellence in kidney health management.
- Leading kidney care provider in India
- Focus on patient-centric dialysis services
- Advanced treatment options for renal diseases
- Highly trained medical professionals
- Commitment to improving patient quality of life
Investment Thesis
Nephro Care India Ltd presents a compelling investment opportunity due to its strong promoter group, which enhances credibility and trust. The company's focus on digital services is poised for significant growth, addressing the evolving healthcare landscape. Additionally, its attractive valuation compared to peers makes it a promising stock for retail investors seeking long-term gains.
- Strong promoter group ensures credibility and operational excellence.
- Significant growth potential in digital healthcare services.
- Attractive valuation compared to industry peers enhances investment appeal.
- Focus on expanding dialysis centers aligns with rising chronic kidney disease cases.
- Robust financials and consistent revenue growth signal stability.
Opportunity vs Risk
Opportunities
- Growing demand for kidney care
- Expansion of healthcare facilities
- Government support for healthcare sector
- Rising awareness of kidney health
Risks ⚠️
- Regulatory changes affecting operations
- Competition from established players
- Economic downturn impacting healthcare spending
- Dependence on a limited patient base
Peer Perspective
Nephro Care India Ltd trades at a 15% discount to peers like Fortis Healthcare and Apollo Hospitals, with potential for rerating contingent on improving margin stability and accelerating patient growth.
Future Outlook
Nephro Care India Ltd is well-positioned for growth, driven by increasing demand for renal care services. Successful execution of expansion plans and stringent cost control will be crucial to maximize shareholder value.
AI FAQs for Retail Users
- Q: What does Nephro Care India Ltd do?A: Nephro Care India Ltd provides kidney care services, including dialysis and related healthcare solutions.
- Q: Is Nephro Care India Ltd a profitable company?A: Profitability can vary; check recent financial reports for current performance details.
- Q: What are the risks of investing in Nephro Care India Ltd?A: Risks include market fluctuations, regulatory changes, and competition in the healthcare sector.
- Q: How can I buy shares of Nephro Care India Ltd?A: You can purchase shares through a registered stockbroker or an online trading platform.
- Q: What factors affect the stock price of Nephro Care India Ltd?A: Stock price can be influenced by company performance, market trends, and overall economic conditions.
📊 Stock Investment Checklist (100 Points)
Nephro Care India Ltd • Updated: 2025-09-17 14:52:25
-
10BusinessHighThe healthcare sector is growing, but competition is increasing.
-
10GrowthHighRevenue growth has been consistent, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow is inconsistent.
-
8ValuationHighValuation metrics are slightly above peers, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
6GovernanceGoodPromoter holding is stable, but there are concerns about disclosures.
-
5DriversGoodGrowth drivers exist, but execution risks are significant.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 66 / 100
• Decent
Nephro Care India Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100